Adamax

Last updated
Adamax
Adamax structure.png
Chemical and physical data
Formula C50H69N11O11S
Molar mass 1032.23 g·mol−1
3D model (JSmol)
  • O=C(N)C12CC3(NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CCSC)CCC(O)=O)Cc4nc[NH]c4)Cc4ccccc4)CC(C1)CC(C3)C2
  • InChI=InChI=1S/C50H69N11O11S/c1-29(62)55-35(14-17-73-2)43(67)56-34(12-13-41(64)65)42(66)57-36(20-33-25-52-28-54-33)44(68)58-37(19-30-8-4-3-5-9-30)47(71)61-16-7-10-38(61)45(69)53-26-40(63)60-15-6-11-39(60)46(70)59-50-23-31-18-32(24-50)22-49(21-31,27-50)48(51)72/h3-5,8-9,25,28,31-32,34-39H,6-7,10-24,26-27H2,1-2H3,(H2,51,72)(H,52,54)(H,53,69)(H,55,62)(H,56,67)(H,57,66)(H,58,68)(H,59,70)(H,64,65)/t31?,32?,34-,35-,36-,37-,38-,39-,49?,50?/m0/s1
  • Key:SWAHDDQBIQRRFH-MHNCVWKMSA-N

Adamax (Ac-MEHFPGPAG-NH2) is a synthetic peptide derivative that is a designer analogue of semax, described as semax modified with the N-terminal and C-terminal modifications found in Peptide 021. It has been identified as a designer drug in border seizures and classified as a prescription medicine in New Zealand. [1]

References

  1. ↑ "Classification of Unscheduled Peptides. Submission to the Medicines Classification Committee" (PDF). Medsafe. New Zealand Medicines and Medical Devices Safety Authority. June 2025.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.